Frank Scholz has joined AlixPartners as a managing director and one of the key leaders in the firm’s global Healthcare and Life Sciences practice, focusing on efforts in the pharmaceutical sector.
He will be based in AlixPartners’ Chicago office.
Scholz brings more than 20 years of high-level industry experience and broad-based consulting experience to his new position, and has deep experience in generics and branded pharmaceuticals, product commercialization, research & development, supply chain operations, quality management, and international M&A.
He joins AlixPartners from Mallinckrodt Pharmaceuticals, where he spent more than six years, and most recently was executive vice president and chief operations & digital innovation officer. His responsibilities included commercial and R&D oriented strategic alliances, digital innovation, information technology, merger integration, strategic programs, procurement, global quality, and global operations for branded products.
Earlier in his career, he spent 16 years at consulting firm McKinsey & Company, where he rose to the level of partner, served clients globally in the pharmaceutical and medical devices industries, as well as in select other industries, including high technology.
“We are extremely pleased to welcome Frank to AlixPartners,” said Simon Freakley, CEO of AlixPartners. “Disruption is hitting healthcare and life sciences companies like never before, and Frank’s broad experience and deep knowledge will prove invaluable to clients looking to turn that disruption into advantage.”
